Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment

Xuemeng Xu1,2, Qiu Peng1, Xianjie Jiang1

  • 1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.

Insights

Cancer cells exhibit metabolic plasticity, reprogramming their metabolism through epigenetic changes. Understanding these epigenetic modifications, including DNA methylation and histone lactylation, is key to developing new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer cells undergo metabolic reprogramming and epigenetic modifications.
  • Metabolic pathway activity in tumors is plastic and changes during progression.
  • Metabolic and epigenetic changes are interconnected, influencing tumor pathogenesis.

Purpose of the Study:

  • To review recent studies on epigenetic modifications regulating cancer cell metabolism.
  • To explore mechanisms of epigenetic regulation in glucose, lipid, and amino acid metabolism.
  • To highlight the role of epigenetic factors in tumor growth and therapeutic strategies.

Main Methods:

  • Literature review of recent studies on cancer metabolism and epigenetics.
  • Focus on mechanisms of DNA methylation, chromatin remodeling, noncoding RNAs, and histone lactylation.
  • Analysis of the interplay between epigenetic changes and metabolic reprogramming in cancer.

Main Results:

  • Epigenetic modifications significantly influence cancer cell metabolism.
  • DNA methylation, chromatin remodeling, noncoding RNAs, and histone lactylation are key epigenetic regulators.
  • These epigenetic changes impact glucose, lipid, and amino acid metabolism in tumors.

Conclusions:

  • Epigenetic modifications are crucial for metabolic reprogramming in cancer cells.
  • Targeting epigenetic mechanisms offers potential for novel cancer therapeutics.
  • Further research into these mechanisms can advance our understanding of tumor pathogenesis.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K